Navigation Links
The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance
Date:11/12/2008

WELLINGTON, Fla., Nov. 12 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP) (http://www.QuantumMD.com), a Wellington, Florida based healthcare organization, in anticipation of a scheduled presentation to be delivered at Paulson Investment's Westergaard Conference by Quantum President & CEO Noel J. Guillama later this morning, announced today that it has increased the active patient base to over 3,650 using the community health systems (CHS) established by Quantum subsidiary, Renaissance Health System of Florida, Inc.(http://www.rhsfl.com/)

The Company also announced that it has begun the process of closing year end financials as October 31st marked the conclusion of fiscal year 2008. The Company expects actual audited results on or about January 29, 2009 and notes that the extensive process includes the financial reconciliation with numerous health plan partners. At this time, Quantum anticipates reporting revenues in the range of $15 to $16 million for fiscal year 2008. Further, the Company believes this figure translates to an annualized run rate greater than $25 million and expects this growth trend to continue to accelerate through 2009.

The traditional Medicare Advantage Open Enrollment period begins November 15, 2008. Noel J. Guillama, President & CEO, commented, "We are pleased to have demonstrated continued growth as we prepare for Open Enrollment to commence. I look forward to sharing this news with the attendees at the Westergaard Conference during today's presentations."

Mr. Guillama is presenting at Westergaard with Pete Martinez, Senior Vice President and Chief Technology & Innovations Officer for Quantum. The Company is scheduled to present at 10:10 a.m., 11:55 a.m., 3:15 p.m., and 5:00 p.m. The conference is being held at the Waldorf Astoria, 301 Park Avenue, New York City, New York.

Additionally, Mr. Guillama provided his interpretation of President-Elect Obama's Healthcare Agenda through a Letter to the Shareholders on November 6, 2008. The letter can be viewed on the Company website http://www.QuantumMD.com/ObamaHealthPlan.

About The Quantum Group, Inc.

The Quantum Group provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.

Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $600 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation's largest and fastest growing industry.

We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the Florida healthcare industry.

In this announcement, the Company has given guidance based on preliminary results from its patient lives under management. Actual results may vary substantially in part due to the actual reporting by the health plan partners under contract including the number of assigned patient lives, enrollments, and retroactive disenrollments. The Company is not required to file updates and/or changes to this guidance prior to the filing of the audited Fiscal Year 2008 results to the Securities and Exchange Commission. Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward- looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to show 2008 fiscal year revenues in the range discussed in this press release, to continue revenue growth trend in fiscal year 2009, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

PR Financial Marketing

Jim Blackman: 713-256-0369

jim@prfmonline.com

or

The Quantum Group, Inc.

Danielle Amodio: 561.798.9800

damodio@quantummd.com


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum light beams good for fast technology
2. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
3. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
4. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
5. Results promising for computational quantum chemical methods for drug development
6. The Quantum Group, Inc. Announces Separation of Units
7. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
8. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
9. The Quantum Group Announces Strategic Technology Alliance
10. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
11. The Quantum Group Extends CEOs Employment Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the ... and suppliers for its inaugural Member Conference at the Paris Hotel in Las ... the operational health of America’s healthcare providers. , The conference was highlighted by ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... The ... Project offering a new model of care for living and healing, celebrated its ... values: Meaningful Life in a Real Home provided by Empowered Staff. , “This is ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... technologies and development solutions for drugs, biologics, consumer health and global clinical supply ... office in Korea to support the company’s continued investment and strategic growth plans ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Memorial Day Weekend ... Amica Insurance is sharing tips to make sure your family and vehicle ... the National Safety Council, there may be 439 deaths and an additional 50,500 serious ...
(Date:5/26/2016)... ... May 26, 2016 , ... North Cypress Medical Center hosted ... Club in Cypress. With the help of community partners, the event organizers raised $45,000 ... hope for wounded service members and their families through health, wellness, and therapeutic support. ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... , May 24, 2016 ... Education in Clinical Neurophysiology  Elsevier , ... products and services, today announced the launch of ... open access journal that focuses on clinical practice issues ... case reports, clinical series, normal values and didactic reviews. ...
Breaking Medicine Technology: